Anchor: closest trading day on/after filing's date_of_event. Source: Yahoo Finance daily adj_close. Past performance is not indicative of future results.
| Filed | Form | Issuer | Stake | Shares | Intent | |
|---|---|---|---|---|---|---|
| 2026-10-06 | SCHEDULE 13G | Atea Pharmaceuticals, Inc.AVIR | — | — | view → | |
| 2026-07-27 | SCHEDULE 13D/A | Nano Dimension Ltd.NNDM | — | 16,715,812 | view → | |
| 2026-06-30 | SCHEDULE 13D | Nano Dimension Ltd.NNDM | — | 14,292,813 | view → | |
| 2026-06-29 | SCHEDULE 13G | Boundless Bio, Inc.BOLD | — | — | view → | |
| 2026-06-10 | SCHEDULE 13G | Fulcrum Therapeutics, Inc.FULC | — | — | view → | |
| 2026-06-04 | SCHEDULE 13D/A | Aurinia Pharmaceuticals Inc.AUPH | 10.00% | 13,044,106 | view → | |
| 2026-05-13 | SCHEDULE 13D/A | Kezar Life Sciences, Inc. | — | 0 | view → | |
| 2025-09-03 | SCHEDULE | iTeos Therapeutics, Inc. | 100.00% | 10,000 | view → | |
| 2025-05-19 | SCHEDULE | Allakos Inc. | 100.00% | 10,000 | view → | |
| 2025-04-03 | SCHEDULE | Allakos Inc. | 9.60% | 8,693,687 | view → | |
| 2025-03-04 | SCHEDULE | Aurinia Pharmaceuticals Inc.AUPH | 7.30% | 10,029,500 | view → | |
| 2025-02-27 | SCHEDULE | ACELYRIN, Inc. | 7.30% | 7,298,328 | view → |
Free. We email you when criteria match. One-click unsubscribe in every email.
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →